Dr. med. Markus Kölle

Oberarzt

E-Mail: markus.koelle@uniklinik-ulm.de

Telefon: 0731 500-61411
Telefax: 0731 500-61412

 

 

Markus Kölle studierte Medizin in Tübingen und promovierte mit einer Arbeit über die Bedeutung retinotoper Kortexareale für die Erkennung von Orientierungskontrast an der Universität Ulm. Er absolvierte seine Ausbildung zum Facharzt für Psychiatrie und Psychotherapie an der Universitätsklinik Ulm. Seit 2013 ist er an der Sprechstunde für ADHS im Erwachsenenalter beteiligt, seit 2018 ist er Oberarzt der Klinik.

Markus Kölle studied medicine in Tübingen and received his doctorate with a thesis on the relevance of retinotopic cortical areas for the detection of orientation contrast at the University of Ulm. He completed his training as a specialist in psychiatry and psychotherapy at the University Hospital of Ulm. Since 2013, he has been involved in ADHD consultations for adults, and since 2018 he has been senior physician at the clinic.

Publikationen

Mackert S, Grön G, Kölle M: Targeting DNA-Methylation in Attention-Deficit- / Hyperactivity-Disorder – a systematic review. (in preparation)

Kölle M, Senel M, Heckel K, Grön G: ADHS-Diagnose und Stimulanzien-Therapie bei einem Patienten mit Multipler Sklerose. Nervenheilkunde 2018; 37(12): 897-900.

Ulrich M, Endres F, Kölle M, Adolph O, Widenhorn-Müller K, Grön G: Glucose moulates food-related salience coding in midbrain neurons in humans. Hum Brain Mapp. 2016 Dec; 37(12): 4376-4384.

Kölle M, Grön G, Kahn N, Brummer D: Komplikationen einer ADS-Behandlung im Erwachsenenalter. Nervenheilkunde 2016; 35 (9): 607-610.  

Gahr M, Freudenmann RW, Kölle MA, Schönfeldt-Lecuona C: From benzodiazepine to pregabalin dependence: different agents, similar problems. Indian J Psychiatry. 2015 Jan-Mar;57(1):111-2.

Gahr M, Kölle MA: Methylphenidate intoxication: somnolence as an uncommon clinical symptom and proof of overdosing by increased serum levels of ritalinic acid. Pharmacopsychiatry. 2014 Sep;47(6):215-8.

Gahr M, Connemann BJ, Freudenmann RW, Kölle MA, Schönfeldt-Lecuona CJ: Animal hoarding: a mental disorder with clinical implications for public health. Fortschr Neurol Psychiatr. 2014 Jun;82(6):330-6.

Gahr M, Freudenmann RW Hiemke C, Kölle MA, Schönfeld-Lecuona C: Abuse of methylphenidate in Germany: data from spontaneous reports of adverse drug reactions. Psychiatry Res. 2014 Jan 30;215(1):252-4.

Gahr M, Freudenmann RW, Connemann BJ, Kölle MA, Schönfeldt-Lecuona C: Dependence on flupirtine.  J Clin Pharmacol. 2013 Sep;53(9):1003-4.

Gahr M, Schönfeldt-Lecuona C, Kölle MA, Freudenmann RW: Intoxications with the monoamine oxidase inhibitor tranylcypromine: an analysis of fatal and non-fatal events. Eur Neuropsychopharmacol. 2013 Nov;23(11):1364-72.

Gahr M, Schönfeldt-Lecuona C, Kölle MA, Pfenninger E, Freudenmann RW: Electroconvulsive therapy in patients with diagnoses other than major depression and/or difficult characteristics: a combined psychiatric-anesthesiological approach based on retrospective chart analysis. Psychiatry Res. 2013 Nov 30;210(1):159-65.

Gahr M, Franke B, Freudenmann RW, Kölle M, Schönfeldt-Lecuona C: Concerns about Pregabalin: further experience with its potential of causing addictive behaviors. J Addict Med. 2013 Mar-Apr;7(2):147-9.

Gahr M, Franke B, Freudenmann RW, Kölle MA, Schönfeldt-Lecuona C.: Concerns about pregabalin: further experience with its potential of causing addictive behaviors. J Addict Med. 2013 Mar-Apr;7(2):147-9.

Gahr M, Schönfeldt-Lecuona C, Kölle MA, Freudenmann RW.: Withdrawal and Discontinuation Phenomena Associated with Tranylcypromine: A Systematic Review. Pharmacopsychiatry. 2013 Jan 28.

Gahr M, Freudenmann RW, Hiemke C, Kölle MA, Schönfeldt-Lecuona C.: Pregabalin abuse and dependence in Germany: results from a database query. Eur J Clin Pharmacol. 2013 Jan 5.

Gahr M, Kölle MA, Baumgarten E, Freudenmann RW.: Mania related to mesterolone in a previously mentally healthy person. J Clin Psychopharmacol. 2012 Oct;32(5):734-5.

Gahr M, Kölle MA, Freudenmann RW, Schönfeldt-Lecuona C.: Aseptic gingivitis related to quetiapine hemifumarate. Pharmacopsychiatry. 2013 Jan;46(1):39-40.

Gahr M, Kölle MA, Schönfeldt-Lecuona C. Relapse prevention in alcohol dependence: acamprosate and naltrexone as a combined pharmacological strategy. Nervenarzt. 2012 Aug 15.

Gahr M, Plener PL, Kölle MA, Freudenmann RW, Schönfeldt-Lecuona C.: Self-mutilation induced by psychotropic substances: a systematic review. Psychiatry Res. 2012 Dec 30;200(2-3):977-83.

Gahr M, Gastl R, Kölle MA, Schönfeldt-Lecuona C, Freudenmann RW.: Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report. J Med Case Rep. 2012 Feb 6;6:49.

Gahr M, Kölle MA, Schönfeldt-Lecuona C, Lepping P, Freudenmann RW.: Paliperidone extended-release: does it have a place in antipsychotic therapy? Drug Des Devel Ther. 2011 Mar 11;5:125-46.

Gahr M, Kölle MA, Freudenmann RW. Disorganized schizophrenia does not deteriorate with dopamine agonists cabergoline and bromocriptine used for ablactation. Pharmacopsychiatry. 2011 Mar;44(2):74.

Freudenmann RW, Kölle M, Schönfeldt-Lecuona C, Dieckmann S, Harth W, Lepping P. Delusional parasitosis and the matchbox sign revisited: the international perspective. Acta Derm Venereol. 2010 Sep;90(5):517-9.

Kölle M, Lepping P, Kassubek J, Schönfeldt-Lecuona C, Freudenmann RW. Delusional infestation induced by piribedil add-on in Parkinson's disease. Pharmacopsychiatry. 2010 Aug;43(6):240-2.

Freudenmann RW, Kölle M, Huwe A, Luster M, Reske SN, Huber M, Lepping P, Wolf RC, Schönfeldt-Lecuona C.: Delusional infestation: neural correlates and antipsychotic therapy investigated by multimodal neuroimaging. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1215-22.

Froeba G, Georgieff M, Linder EM, Föhr KJ, Weigt HU, Holsträter TF, Kölle MA, Adolph O.: Intranasal application of xenon: describing the pharmacokinetics in experimental animals and the increased pain tolerance within a placebo-controlled experimental human study. Br J Anaesth. 2010 Mar;104(3):351-8.

Thielscher A, Kölle M, Neumann H, Spitzer M, Grön G.: Texture segmentation in human perception: a combined modeling and fMRI study. Neuroscience. 2008 Feb 6;151(3):730-6

 

Kongressbeiträge

Kölle M, Senel M, Heckel K, Grön G: Stimulant therapy in a case of ADHD and Multiple Sclerosis. World Congress of ADHD, Lisbon 2019 (Poster).

Kölle M, Heckel K, Grön G: Cannabinoid-Therapy in a case of adult ADHD. World Congress of ADHD, Vancouver 2017 (Poster).

Kölle M, Brummer D, Kahn N, Grön G: Complicated treatment in a case of adult ADHD: Bupropion-induced seizure and a temporal arachnoid cyst. World Congress of ADHD, Glasgow 2015 (Poster).

Kölle M, Freudenmann RW: Neural correlates of  delusional infestation. 6th World Congress on Itch, Brest 2011 (Vortrag).

Kölle M, Hefele K, Pfeiffer C, Spitzer M, Freudenmann R, Osterfeld N, Schönfeldt-Lecuona C: Dermatologisch-psychiatrische Therapie bei Dermatotillomanie. Poster, Jahrestagung der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Berlin 2009 (Poster).

Kölle M, Huwe A, Luster M, Reske SN, Spitzer M, Osterfeld N, Schönfeldt-Lecuona C, Freudenmann RW: Multimodales Neuroimaging und antipsychotische Therapie mit Aripiprazol bei substanzinduziertem Dermatozoenwahn. Poster, Jahrestagung der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN) Berlin 2009 (Poster).

Kölle M, Spitzer M, Freudenmann RW: EKT bei wahnhafter Depression nach Neuroborreliose. Poster, Jahrestagung der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Berlin 2008 (Poster).

Kölle M, Thielscher A, Herrnberger B, Meier C, Neumann H, Spitzer M, Grön G (2004) The visual area V4 and pop-out search: an approach combining fMRI and neural networks. Annual Meeting of the Organization for Human Brain Mapping, Budapest 2004 (Poster).